Company news
LSL Pharma Group Inc news in 2025
LSL Pharma Group Inc's news releases, calls and decks from 2025, newest first.
LSL Pharma Group announces closing of the acquisition of juno OTC and final $2M closing of upsized $12M offering
December 23, 2025
LSL Pharma Group closes $10M of upsized $12M brokered offering and enters into definitive agreement for the acquisition of juno OTC
December 23, 2025
LSL Pharma Group announces acquisition of juno OTC Inc. and a brokered private placement of convertible debentures of $11M
December 17, 2025
LSL Pharma Group reports fourth consecutive record quarterly revenues and Q3 2025 financial results
November 20, 2025
LSL Pharma Group completes the acquisition of Laboratoire Du-Var Inc.
November 18, 2025
Health Canada grants LSL Pharma Group approval to commercialize six new sterile ophthalmic solutions
October 28, 2025
LSL Pharma Group announces appointments to its board of directors
October 16, 2025
LSL Pharma Group closes a $2.275M non-brokered private placement
September 2, 2025
LSL Pharma Group reports third consecutive record quarterly revenues and Q2 2025 financial results
August 25, 2025
LSL Pharma Group announces the completion of early redemption of all 11% unsecured convertible debentures
August 4, 2025
LSL Pharma Group enters into non-binding agreement to acquire a quebec-based competitor
July 31, 2025
LSL Pharma Group announces redemption of 11% unsecured convertible debentures
July 2, 2025
LSL Pharma Group announces voting results of its annual general and special meeting of shareholders
June 27, 2025
LSL Pharma Group secures $17.5 million from desjardins and BDC
June 27, 2025
LSL Pharma Group reports record revenues and first quarter 2025 results
May 29, 2025
LSL Pharma Group reports its fourth quarter and year-end 2024 results
May 1, 2025
LSL Pharma Group Inc. announces its participation in the "2025 bloom burton & co. healthcare investor conference"
April 29, 2025
LSL Pharma Group announces the semi-annual interest payment on the convertible debentures listed as LSL.db
April 23, 2025
LSL Pharma Group announces the signing of two agreements to market new ophthalmic products in Canada
April 3, 2025
LSL Pharma Group appoints Louis Laflamme to the board of directors
March 31, 2025
LSL Pharma Group grants share options
January 22, 2025